In conclusion, our data demonstrate that PAK1 inhibition via NVS‐PAK1‐1 protects dendritic spine integrity in AD‐relevant models and modulated multifaceted proteomic changes that counteract disease‐associated synaptic and metabolic dysfunction. The gene discussed is PAK1; the disease is Alzheimer disease.